香港股市 已收市

醫脈通 (2192.HK)

HKSE - HKSE 延遲價格。貨幣為 HKD。
加入追蹤清單
8.720+0.020 (+0.23%)
收市:04:08PM HKT

醫脈通

E1, Red Mnr Intl. Bonded Innovation Park
No. 1 Baijialou Chaoyang North Road Chaoyang District
Beijing
China

https://www.medlive.cn

版塊Healthcare
行業Medical Distribution
全職員工742

高階主管

名稱頭銜支付行使價出生年份
Ms. Liping TianChairwoman & CEO1.72M1967
Mr. Lixin TianPresident, Head of Medical Information Science Research Unit & Executive Director1.32M1969
Mr. Lijun TianVP, Deputy Head of Medical Information Science Research Unit & Executive Director1.24M1974
Ms. Xin ZhouVP & Executive Director624.99k1981
Mr. Jiang NanMedical Director, Chief Editor-Content Team & Dy. Head of Medical Information Science Research Unit1989
Ms. Juan LiuChief Client Officer & Assistant to Chairwoman1985
Ms. Yanling YangJoint Company Secretary
Ms. Cheuk Ting ChuJoint Company Secretary
Mr. Xiaofeng ZhangExecutive
Ms. Lingdi LiuExecutive
截止 2022年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 HKD。

描述

Medlive Technology Co., Ltd., together with its subsidiaries, operates an online professional physician platform in Mainland China and internationally. Its precision marketing and corporate solution provides full service on its one-site platform, which includes project management, clinical monitoring, clinical data management, biostatistics, protocol design, medical monitoring, patient recruitment, and supporting system, as well as digital market research, electronic data capture, real-world studies, and application software development services. The company's medical knowledge solution offers medical education and clinical decision support, including licensing software to physicians, other registered users, such as other healthcare professionals and pharmaceutical companies. Its intelligent patient management solution provides chronic disease management services; and patient education services, which includes content development, application software development, and other related services. The company was formerly known as Kingyee Co., Limited and changed its name to Medlive Technology Co., Ltd. in 2021. Medlive Technology Co., Ltd. was founded in 1996 and is headquartered in Beijing, China.

公司管治

截至 無 止,醫脈通 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。